Nanoformulation: A Useful Therapeutic Strategy for Improving Neuroprotection and the Neurorestorative Potential in Experimental Models of Parkinson's Disease-Reference-Cited by-同舟云学术

Nanoformulation: A Useful Therapeutic Strategy for Improving Neuroprotection and the Neurorestorative Potential in Experimental Models of Parkinson's Disease

Published:2017 Issue: Volume: Page:99-122
ISSN:0074-7742
Container-title:International Review of Neurobiology
language:
Short-container-title:

Author:

Lafuente Jose V.,Requejo Catalina,Carrasco Alejandro,Bengoetxea Harkaitz

Publisher

Elsevier

Reference105 articles.

1. Hyperactivity of remaining dopaminergic neurones after partial destruction of the nigro-striatal dopaminergic system in the rat;Agid;Nature: New Biology,1973

2. Redundant dopaminergic activity may enable compensatory axonal sprouting in Parkinson disease;Arkadir;Neurology,2014

3. Repairing the parkinsonian brain with neurotrophic factors;Aron;Trends in Neurosciences,2011

4. Neurogenesis in the rat neostriatum;Bayer;International Journal of Developmental Neuroscience: The Official Journal of the International Society for Developmental Neuroscience,1984

5. Structures outside the basal ganglia may compensate for dopamine loss in the presymptomatic stages of Parkinson's disease;Bezard;FASEB Journal: Official Publication of the Federation of American Societies for Experimental Biology,2001

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Integrated metabolomics and proteomics analysis of plasma lipid metabolism in Parkinson’s disease;Expert Review of Proteomics;2024-02-15

2. Neurotrophic factors loaded TGN-modified chitosan nanoparticles ameliorate symptoms of MS through GATA3/FOXP3 and targeting Th1/2 cells pathways;Journal of Drug Delivery Science and Technology;2023-08

3. Efficacy of invasive and non-invasive methods for the treatment of Parkinson’s disease: Nanodelivery and enriched environment;Nanowired Delivery of Drugs and Antibodies for Neuroprotection in Brain Diseases with Co-Morbidity Factors Part B;2023

4. Application of Therapeutic Nanoplatforms as a Potential Candidate for the Treatment of CNS Disorders: Challenges and Possibilities;Current Pharmaceutical Design;2022-09

5. Nutritional aspects in Parkinson’s disease;Critical Reviews in Food Science and Nutrition;2021-03-22